|
|||||
|
|
| 2017年风湿免疫病主要临床进展 | |
| 引用本文： | 高丽霞郭惠芳. 2017年风湿免疫病主要临床进展[J]. 临床荟萃, 2018, 33(1): 54-59. DOI: 10.3969/j.issn.1004-583X.2018.01.008 |
| 作者姓名： | 高丽霞郭惠芳 |
| 作者单位： | 河北医科大学第二医院 风湿免疫科， 河北 石家庄050000 |
| 摘 要： | 2017年系统性红斑狼疮、特发性炎症性肌病和ANCA相关性血管炎的诊断标准再次更新， 类风湿关节炎、干燥综合征、脊柱关节炎以及痛风等多个管理指南相继出台，并且不断细化。抗风湿药物的使用规范越来越详细，糖皮质激素、非甾体抗炎药的不良反应也引起了高度关注，并推出了国内专家共识。风湿病的诊治策略越来越丰富，管理越来越规范。 |
| 关 键 词： | 风湿病 红斑狼疮 系统性 关节炎 类风湿 干燥综合征 药物 治疗策略 |
Major advances in clinical research of rheumatic diseases of 2017 |
|
| Gao Lixia,Guo Huifang. Major advances in clinical research of rheumatic diseases of 2017[J]. Clinical Focus, 2018, 33(1): 54-59. DOI: 10.3969/j.issn.1004-583X.2018.01.008 | |
| Authors: | Gao Lixia Guo Huifang |
| Affiliation: | Department of Rheumatology and Immunology， the Second Hospital of Hebei Medical University， Shijiazhuang 050000， China |
| Abstract: | In 2017， the diagnostic criteria of systemic lupus erythematosus，idiopathic inflammatory myopathies and anti neutrophil cytoplasmic antibody associated vasculitis have been renewed. Multiple management guidelines， for example rheumatoid arthritis， Sjogren's syndrome spondyloarthritis and gout etc， have been published and refined. The use of anti rheumatic drugs become more and more detailed， and the adverse reaction of glucocorticoid and non steroidal anti inflammatory drugs has also aroused great concern. And then， domestic expert consensus have been introduced. The diagnosis and treatment strategy of rheumatic diseases become more and more abundant， and the management methods also become more and more standard. |
| Keywords: | rheumatic disease lupus erythematosus arthritis rheumatoid Sjgren’s syndrome drug；treatment strategy |
| 本文献已被 维普 等数据库收录！ | |
| 点击此处可从《临床荟萃》浏览原始摘要信息 | |
| 点击此处可从《临床荟萃》下载全文 | |